期刊文献+

原发性高血压患者血尿酸、血胱抑素C和肌酐值的观察 被引量:2

A Survey of Serum Uric Acid,Cystatin C and Creatinine Levels in Essential Hypertension
下载PDF
导出
摘要 目的:观察原发性高血压(EH)患者血尿酸(UA)、血胱抑素C(Cys C)和肌酐(Cr)值,探讨其临床意义。方法:血尿酸和肌酐用酶法在全自动生化分析仪上测定,血胱抑素用比浊法在特定蛋白仪上测定。结果:200例EH患者伴发高尿酸血症(HUA)88例,其Cys C值(1.12±0.14)mg/L和Cr值(141.5±93.5)μmol/L明显高于非HUA者(P<0.05);随着年龄的增长和高血压分期的增加而明显升高,但Cr升高率明显后于Cys C的升高率和HUA的发生率(P<0.05)。结论:EH患者Cys C、Cr与HUA关系密切;UA、Cys C升高在Cr之前;UA是EH患者肾损害的早期表现。 Objective: To survey serum uric acid(UA),cystatin C(Cys C) and creatinine(Cr) levels in patients with essential hypertension(EH),and study its clinical significance.Methods: UA and Cr were measured by enzymatic method with automatic biochemistry analyzer,Cys C was measured by nephelometry with specific protein aparatus.Results: 88 cases were accompanied with hyperuricemia(HUA) in 200 patients with EH.Their mean Cys C value(1.12±0.14) mg/L and mean Cr value(141.5±93.5) μmol/L were higher than those in the patients without HUA significantly(P0.05),and increased with the growth of age and stages of hypertension.However,the rising rate of Cr value was lower than Cys C and HUA incidence(P0.05).Conclusion: Cys C and Cr values have close relation with HUA in patients with EH.UA and Cys C values rise before Cr value.UA is an early manifestation of impairment of renal function in patients with EH.
作者 张洪波
出处 《江汉大学学报(自然科学版)》 2012年第1期98-100,共3页 Journal of Jianghan University:Natural Science Edition
关键词 原发性高血压 尿酸 肌酐 胱抑素C essential hypertension uric acid creatinine cystatin C
  • 相关文献

参考文献5

二级参考文献17

  • 1李海霞,张春丽,徐国宾,王学晶,李淑葵,李志艳,张旭初,夏铁安.健康人群血清半胱氨酸蛋白酶抑制剂C与肌酐分布及其评价慢性肾脏病患者肾小球滤过功能的比较研究[J].中华检验医学杂志,2006,29(11):970-974. 被引量:179
  • 2俸家富,陈婷梅,涂植光.感染HBV或HCV的肝病患者血清半胱氨酸蛋白酶抑制剂C的改变[J].中华检验医学杂志,2006,29(11):987-990. 被引量:28
  • 3中华神经科学会 中华神经外科学会.脑血管疾病分类(1995)[J].中华神经科杂志,1996,29(3):233-235.
  • 4Randers E, Erlandsen EJ. Serum cystatin C as an endogenous marker of the renal function-a review. Clin Chem Lab Med, 1999,37:389-395.
  • 5Dharnidharka VR,Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function : a meta-analysis.Am J Kidney Dis,2002,40:221-226.
  • 6National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.Am J Kidney Dis,2002,39(2 Suppl 1 ) :S1-266.
  • 7Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine : a new prediction equation. Ann Intem Med, 1999,130:461-470.
  • 8Norlund L, Fex G, Lanke J, et al. Reference intervals for the glomerular filtration rate and cell-proliferation markers : serum cystatin C and serum beta2-microglobulin/cystatin C ratio. Scand J Clin Lab Invest, 1997,57:463-470.
  • 9Newman DJ, Thakkar H, Edwards RG, et al. Serum cystatin C measured by automated immunoassay : a more sensitive marker of changes in GFR than serum creatinine. Kidney Int, 1995,47 : 312-318.
  • 10Erlandsen E J, Randers E, Kristensen JH. Reference intervals for serum cystatin C and serum creatinine in adults. Clin Chem Lab Med, 1998,36:393-397.

共引文献192

同被引文献26

  • 1全国血压抽样调查协作组.中国人群体重指数及其与血压关系现况抽样调查研究[J].高血压杂志,1995,3(A01):31-35. 被引量:31
  • 2方顺源,朱晓霞,金达丰,刘庆敏,施世锋,李安乐,陈仁华.高血压与肥胖、高血脂、高血糖及高尿酸血症的关系[J].中国慢性病预防与控制,2006,14(1):33-35. 被引量:52
  • 3Xiao- Hua Zhou,Nancy A, Obuchowski, et al.诊断医学统计学[M].北京:人民卫生出版社,2005:22-30.
  • 4WATANABE S, OKURA T, LIU J, et al. Serum cystatin C level is a marker of end-organ damage in patients with essential hypertension[J]. Hypertens Res, 2003, 26(11) ,895-899.
  • 5JUAN GP, LUIS M,MANUEL LUQUE, et al. Glucose me- tabolism in patients with essential hypertension[J]. Am J Med, 2006, 119(4) ~318-326.
  • 6INKER LA,OKPARAVERO A. Cystatin C as a marker of glo- merular filtration rate: prospects and limitations[J]. Curr Opin Nephrol Hypertens, 2011, 20(6) :631-639.
  • 7HERGET-ROSRNTHAL S,MARGGRAF G, HUSING G, et al. Early detection of acute renal failure by serum cystatin C [J]. Kidney Int, 2004, 66(3)~1115-1122.
  • 8BRIGUORI C,VISCONTI G,RIVERA NV, et al. Cystatin C and contrast-induced acute kidney injury E J ]. Circulation, 2010, 121(19) :2117-2122.
  • 9MALYSZKO J. Biomarkers of acute kidney injury in different clinical settings: a time to change the paradigm? [J]. Kidney Blood Press Res, 2010, 33(5):368-382.
  • 10PERALTA CA, WHOOLEY MA, IX JH, et al. Kidney func- tion and systolic blood pressure new insights from cystatin C: data from the heart and soul study[J]. Am J Hypertens, 2006, 19(9) :939-946.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部